Literature DB >> 7137238

Enhanced reactivity of the platelet thromboxane pathway in normotensive and hypertensive pregnancies with insufficient fetal growth.

H C Wallenburg, N Rotmans.   

Abstract

The reactivity of the platelet thromboxane pathway was investigated by means of measurement of thrombin-induced formation of malondialdehyde in platelets obtained from 26 women in the third trimester of uncomplicated pregnancies, 27 patients with normotensive pregnancies who were delivered of small--for--gestational age infants, 27 patients with pregnancy-induced hypertension and infants with normal birth weights, and 20 patients with pregnancy-induced hypertension and small--for--gestational age infants. Platelet life span and distribution of platelet volumes were also determined. In normotensive and hypertensive pregnant women with small--for--gestational age infants, platelet malondialdehyde formation was significantly increased, and platelet life span was reduced as compared with the other groups. The enhanced reactivity of the platelet thromboxane pathway may be expected to contribute to the increased in vivo platelet activation and consumption which occur in pregnancies with chronic placental insufficiency. Deficient production of placental vascular prostacyclin might be the underlying cause.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7137238     DOI: 10.1016/0002-9378(82)90220-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

Review 1.  Eclampsia still kills.

Authors:  C W Redman
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-30

2.  Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU High-Risk Aspirin Study.

Authors:  G S Moore; A A Allshouse; A L Post; H L Galan; K D Heyborne
Journal:  J Perinatol       Date:  2014-12-04       Impact factor: 2.521

3.  Effect of the antihistaminic drug Bromadryl on ex vivo platelet functions during gestation in rats.

Authors:  V Jancinová; M Petríková; E Ujházy; R Nosál
Journal:  Agents Actions       Date:  1994-06

4.  Changes in serum fibronectin levels at delivery in pregnant women and their fetuses with idiopathic fetal growth retardation.

Authors:  Z H Wang; W J Li; S X Tong
Journal:  J Tongji Med Univ       Date:  1992

5.  Fatty acid composition of umbilical arteries and veins: possible implications for the fetal EFA-status.

Authors:  G Hornstra; A C van Houwelingen; M Simonis; J M Gerrard
Journal:  Lipids       Date:  1989-06       Impact factor: 1.880

6.  Platelet specific proteins (beta-thromboglobulin and platelet factor 4) in normal pregnancy and in pregnancy complicated by preeclampsia.

Authors:  P Csaicsich; J Deutinger; G Tatra
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

7.  Specific therapy in severe fetal intrauterine growth retardation: failure of prostacyclin.

Authors:  S A Steel; J M Pearce
Journal:  J R Soc Med       Date:  1988-04       Impact factor: 18.000

8.  Maternal plasma miRNAs as potential biomarkers for detecting risk of small-for-gestational-age births.

Authors:  Sung Hye Kim; David A MacIntyre; Reem Binkhamis; Joanna Cook; Lynne Sykes; Phillip R Bennett; Vasso Terzidou
Journal:  EBioMedicine       Date:  2020-11-28       Impact factor: 8.143

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.